Management of Acute Myeloid Leukemia in 2020: A Paradigm Shift for Older Adults? SPOC
Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
- Discuss pathogenesis/etiology of AML
- Explain diagnostic testing in AML
- Describe management of AML in older patient populations in the context of recent drug approvals
Joshua Zeidner, MD
Presenter Disclosure Information
Joshua Zeidner, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.
This Non-Credit Course does NOT have accreditation for continuing education credits.
The course offers only general participation certificates.
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth